Indian markets witnessed notable activity in Monday's session, with several stocks displaying significant upward movement within the Nifty Midcap 150 index. As of 12:30 PM, Ola Electric, Vodafone Idea, and Max Healthcare were identified as top gainers, reflecting positive investor sentiment. These gains highlight the dynamic nature of the market, with specific sectors and companies experiencing favorable trading conditions.
Ola Electric led the pack with a 13.82% increase, reaching Rs 45.30. Vodafone Idea followed, gaining 6.28% to trade at Rs 7.62. Max Healthcare also saw a substantial rise of 3.26%, with its shares priced at Rs 1,259.00. KEI Industries and Ashok Leyland also registered notable gains of 3.07% and 2.98% respectively.
Examining the financial performance of Vodafone Idea, the company's consolidated revenue for the year ending March 2025 stood at Rs 43,571.30 Crore, up from Rs 42,651.70 Crore in the previous year. However, the company reported a net loss of Rs 27,385.20 Crore for the same period. On a quarterly basis, Vodafone Idea's revenue for the quarter ending March 2025 was Rs 11,013.50 Crore, while the net loss amounted to Rs 7,168.10 Crore.
Key financial data for Vodafone Idea is presented below:
| Financial Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS (Rs) |
|---|---|---|---|
| Mar 2025 | 43,571.30 | -27,385.20 | -4.01 |
| Mar 2024 | 42,651.70 | -31,232.90 | -6.41 |
| Mar 2023 | 42,177.20 | -29,301.60 | -8.43 |
| Mar 2022 | 38,515.50 | -28,246.60 | -9.83 |
| Mar 2021 | 41,952.20 | -44,464.50 | -15.40 |
Comparing the quarter ending March 2025 with the quarter ending March 2024, Vodafone Idea's revenue increased from Rs 10,573.70 Crore to Rs 11,013.50 Crore, while net loss decreased from Rs -7,672.00 Crore to Rs -7,168.10 Crore.
Max Healthcare's financial performance shows consistent growth. The company's consolidated revenue for the year ending March 2025 reached Rs 7,028.46 Crore, a significant increase from Rs 5,406.02 Crore the previous year. Net profit also rose to Rs 1,075.88 Crore. On a quarterly basis, Max Healthcare's revenue for the quarter ending March 2025 was Rs 1,909.74 Crore, with a net profit of Rs 319.00 Crore.
A summary of Max Healthcare's financials is provided below:
| Financial Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS (Rs) |
|---|---|---|---|
| Mar 2025 | 7,028.46 | 1,075.88 | 11.07 |
| Mar 2024 | 5,406.02 | 1,057.64 | 10.89 |
| Mar 2023 | 4,562.60 | 1,103.51 | 11.38 |
| Mar 2022 | 3,931.46 | 605.05 | 6.25 |
| Mar 2021 | 2,504.67 | -114.50 | -1.59 |
Max Healthcare announced a final dividend of Rs 1.50 per share on May 20, 2025, with an effective date of July 4, 2025. This follows previous dividends of Rs 1.50 per share announced on May 22, 2024, and Rs 1.00 per share announced on May 16, 2023.
KEI Industries also demonstrated strong financial results. For the year ending March 2025, the company's consolidated revenue was Rs 9,735.88 Crore, up from Rs 8,104.08 Crore in the previous year. Net profit increased to Rs 696.41 Crore. On a quarterly basis, KEI Industries reported revenue of Rs 2,914.79 Crore and net profit of Rs 226.55 Crore for the quarter ending March 2025.
The financial data for KEI Industries is detailed below:
| Financial Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS (Rs) |
|---|---|---|---|
| Mar 2025 | 9,735.88 | 696.41 | 75.65 |
| Mar 2024 | 8,104.08 | 580.85 | 64.37 |
| Mar 2023 | 6,912.33 | 477.34 | 52.94 |
| Mar 2022 | 5,726.55 | 375.98 | 41.77 |
| Mar 2021 | 4,181.54 | 273.31 | 30.47 |
KEI Industries announced an interim dividend of Rs 4.00 per share on January 3, 2025, with an effective date of January 27, 2025. The company also split its shares from a face value of Rs 10 to Rs 2 on June 28, 2004.
Ashok Leyland's consolidated revenue for the year ending March 2025 reached Rs 48,535.14 Crore, up from Rs 45,790.64 Crore in the previous year. The company's net profit rose to Rs 3,351.21 Crore. On a quarterly basis, Ashok Leyland posted revenue of Rs 14,695.55 Crore and net profit of Rs 1,234.38 Crore for the quarter ending March 2025.
Key financials for Ashok Leyland are shown below:
| Financial Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS (Rs) |
|---|---|---|---|
| Mar 2025 | 48,535.14 | 3,351.21 | 10.58 |
| Mar 2024 | 45,790.64 | 2,679.96 | 8.46 |
| Mar 2023 | 41,672.60 | 1,350.91 | 4.23 |
| Mar 2022 | 26,237.15 | -292.97 | -1.22 |
| Mar 2021 | 19,454.10 | -69.10 | -0.56 |
Ashok Leyland announced an interim dividend of Rs 4.25 per share on May 13, 2025, with an effective date of May 22, 2025. The company also has a bonus issue with a record date of July 16, 2025, and an ex-bonus date of July 16, 2025, with a bonus ratio of 1:1.
Overall, the market dynamics reflect a mix of growth and challenges across different sectors. While some companies demonstrated significant revenue and profit increases, others continue to navigate financial difficulties. Investors are likely monitoring these factors as they make investment decisions.
The gains made by Ola Electric, Vodafone Idea, Max Healthcare, KEI Industries and Ashok Leyland underscore the diverse opportunities present in the Indian stock market, as of Moneycontrol analysis.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
